Researchers at Korea's state-run National Cancer Center say they've successfully detected circulating tumor cells in patients with breast cancer in its early stages, by just looking at a sample of their blood.
"We developed a magnetic, polymer nanowire coated with an antibody that captures the protein within the circulating tumor cells -- cancer cells, in this case. We were able to detect cancer cells in 41 patients by placing these nanowires into their blood samples."
Circulating tumor cells, or CTCs, are cells that have been shed by a primary tumor into the blood stream.
CTCs are known as the biomarkers of several types of the disease, such as breast, prostate and colorectal cancers.
Until now, CTC monitoring has been limited to cancers in the more advanced stages.
So the ability to find cancer early through blood testing is truly a landmark achievement.
"Once the cancer is spread, treatment becomes more complicated and generally the patient's chance of survival also drops. So it's crucial to get an early diagnosis, which widens the range of possible treatments."
The team is now testing the technology on ovarian and lung cancer patients, too, with high hopes that soon doctors will no longer have to remove a patient's tissue -- what's known as a biopsy -- and can instead simply take a sample of blood.
Lee Unshin Arirang News.
본 저작물 중 본문에 해당하는 뉴스 스크립트는 공공누리 제1유형-출처표시 조건에 따라 이용할 수 있습니다.
단, 영상 자료는 저작권 문제로 자유이용이 제한되니, 담당자에게 확인하여 주시기 바랍니다.
(국제방송교류재단 김형선 : ☎02-3475-5263)